[6] In a study comparing the mechanism of action of BPC-157 with becaplermin (PDGF-BB), a peptide suggested for lower extremity ulcers, the expression of EGR-1 was investigated
Severe reactions like facial swelling, blistering, or burning sensations affect less than 5% of users but require immediate discontinuation and medical evaluation
Although the genetic heritability of fibromyalgia is not well understood, having a family member with fibromyalgia greatly increases risk, suggesting a genetic contribution to susceptibility
BPC-157 dosing protocols differ significantly between oral and injectable routes, reflecting bioavailability differences and therapeutic goals
Wat zegt de wetenschap: dieronderzoek versus mensen De eerste resultaten waren zo positief dat onderzoekers dachten aan een nieuwe categorie middelen die het lichaam zou kunnen beschermen tegen schade
Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers